HB1356
Type: B Origin: House Washington Comments: 0

Reducing Prescription Drug Costs By Eliminating Barriers Impeding Access To Biosimilar Medicines.

Summary
User Reviews

AI Summary

The bill aims to lower prescription drug costs by removing obstacles that hinder access to biosimilar medications. It focuses on promoting the use of more affordable biosimilars by addressing barriers such as patent thickets and anti-competitive practices. By increasing competition in the market, the bill seeks to reduce drug prices and improve patient access to cost-effective treatments.

Bill Activity

  • 2023-01-16: First reading, referred to Health Care & Wellness.

  • 2024-01-08: By resolution, reintroduced and retained in present status.

Overall Bill Rating

0.0
0.0
0.0
0.0
0.0
0.0
Text Versions (1)
Bill Discussion Board

Share your views on the Bill

User Icon

Min. 50 characters required  |  (0/1000 Character)

Contributions (0)
Add Contribution+2 pts.

Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.